Business UpdateOct 9, 2026, 06:06 AM
Alterity Therapeutics CEO to Present at Canaccord Conference
AI Summary
Alterity Therapeutics announced that CEO David Stamler will present at the Canaccord Genuity Drug and Device Conference on October 12, 2026. Dr. Stamler will deliver a corporate presentation focusing on the company's disease-modifying treatments for neurodegenerative diseases and will also engage in roundtable discussions with investors.
Key Highlights
- Alterity Therapeutics CEO David Stamler to present at Canaccord Genuity Drug and Device Conference on October 12, 2026.
- Presentation will cover corporate updates and disease-modifying treatments for neurodegenerative diseases.
- CEO will also host roundtable discussions with investors at the conference.
Price Impact
More from ATHE
More in Business Update